Spry Health Loop
Continuous vital signs monitoring wearable for remote patient monitoring
Company profile
Company profile
Spry Health is a medical technology company specializing in remote patient monitoring through advanced wearable devices. The company develops continuous monitoring solutions designed to track vital signs and health metrics for patients in non-clinical environments. Spry Health's technology enables healthcare providers to remotely monitor patient health status, supporting early intervention and proactive care management. The company's wearable platform is designed to capture physiological data continuously, providing clinicians with actionable insights to improve patient outcomes. Spry Health serves healthcare systems, providers, and organizations looking to extend care beyond hospital walls through digital health monitoring. The company's solutions aim to bridge the gap between episodic clinical visits and continuous health management, particularly for chronic disease management and post-acute care scenarios.
Company description Spry Health official website
Claim this profile to manage Company information and connect with the Health AI Central audience.
01 · Operating footprint
Company-profile context for clinical focus, customers, deployment, integration, milestones, and partnerships.
No clinical focus areas are currently listed.
Hybrid deployment with recorded integration context.
02 · Flagship portfolio
Selected source-backed Company products and the available commercial context.
Continuous vital signs monitoring wearable for remote patient monitoring
03 · Research intelligence
Publications, preprints, clinical validation, and regulatory records in Evidence Position order.
Publications, clinical validation, and regulatory records connected to this Company appear here.
Research
BJU international · Sep 1, 2009
3D radiotherapy can be safely combined with sandwich systemic gemcitabine chemotherapy in the management of pancreatic cancer: factors influencing outcome.International journal of radiation oncology, biology, physics · Apr 1, 2008
Adverse effects to quality of life arising from treatment can recover with intermittent androgen suppression in men with prostate cancer.European journal of cancer (Oxford, England : 1990) · May 1, 2006
Clinical validation
No linked records are currently available.
Regulatory
K181352 · 510k · Mar 29, 2019
04 · Company-reported outcomes
Company-reported outcomes and customer stories are distinct from linked Research Intelligence evidence.
No Company-reported outcomes are currently listed.
05 · Leadership
Leadership profiles and professional links from the current Company record.
No active leadership profiles are currently listed.
06 · Company updates
Recent articles published on Spry Health's official website.
No Company updates are currently listed.
07 · HAIC coverage
Health AI Central reporting that mentions this Company.
No HAIC coverage is currently linked to this Company.
08 · Official presence
Curated official destinations from the active Company record.
09 · Market pathway
Other active Companies in the same market, selected alphabetically from the HAIC directory.
Market context
Companies providing AI-powered remote patient monitoring solutions, wearable health devices with AI analytics, continuous health tracking, or platforms that monitor patients outside clinical settings. Includes general wellness wearables with AI coaching, respiratory monitoring devices, and connected health platforms that aggregate and analyze physiological data from sensors.
Explore the full market directory or compare this Company with additional active profiles.
View all Companies in this market10 · Pro research
Expanded Company research is in development.
Health AI Central Pro · Coming Soon
Pro Research will introduce expanded technical context, linked evidence analysis, and comparative Company research.
Linked research, clinical, and regulatory source pathways.
Expanded product, deployment, integration, and partnership research.
Record-level provenance and review context.